Inicio › Enfermedad de Alzheimer › Carolina del Norte
Ensayos clínicos de Enfermedad de Alzheimer en Carolina del Norte
21 estudios sobre Enfermedad de Alzheimer buscan participantes en Carolina del Norte.
Ciudades en Carolina del Norte
Texto oficial del estudio (inglés)
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- New Hope Clinical Research, Charlotte
- AMC Research, LLC, Matthews
ReclutandoFase 2
Edades de 55 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT06540833A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- West Clinical Research, Morehead City
ReclutandoFase 3
Edades de 55 a 90 · Todos los sexos · Actualizado el 28 sept 2026 · NCT06937229A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Triad Clinical Trials - 515 College Rd, Greensboro
- AMC Research, LLC - Flourish - PPDS, Matthews
- West Clinical Research, Morehead City
ReclutandoFase 3
Edades de 55 a 90 · Todos los sexos · Actualizado el 22 sept 2026 · NCT06585787Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Triad Clinical Trials, Greensboro
ReclutandoFase 3
Edades de 50 a 90 · Todos los sexos · Actualizado el 21 sept 2026 · NCT07177352A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- West Clinical Research, Morehead City
ReclutandoFase 3
Edades de 55 a 90 · Todos los sexos · Actualizado el 16 sept 2026 · NCT07011745ADRC Clinical Cohort (Alzheimer's Disease)
- Duke University, Durham
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 25 a 80 · Todos los sexos · Actualizado el 3 sept 2026 · NCT06703541Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- New Hope Clinical Research, Charlotte
- UNC Health REX Hospital, Raleigh
ReclutandoFase 2
Edades de 55 a 90 · Todos los sexos · Actualizado el 1 sept 2026 · NCT06808984A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- AMC Research, LLC ( Site 1006), Matthews
ReclutandoFase 2
Edades de 50 a 85 · Todos los sexos · Actualizado el 26 ago 2026 · NCT07033494A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- Duke University, Durham
ReclutandoFase 1
Edades de 50 a 85 · Todos los sexos · Actualizado el 24 ago 2026 · NCT06297590A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- AMC Research, LLC, Matthews
ReclutandoFase 3
Edades de 60 a 85 · Todos los sexos · Actualizado el 20 ago 2026 · NCT06976216Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Duke University Medical Center, Durham
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 4 ago 2026 · NCT06563895A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
- Flourish Research, Matthews
ReclutandoFase 1/2
Edades de 35 a 85 · Todos los sexos · Actualizado el 10 jul 2026 · NCT05462106A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Monroe Biomedical Research, Monroe
ReclutandoFase 3
Edades de 55 en adelante · Todos los sexos · Actualizado el 7 jul 2026 · NCT07602582A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- UNC Hosp Invest Drug Serv Pharm, Chapel Hill
ReclutandoFase 2
Edades de 50 a 85 · Todos los sexos · Actualizado el 26 jun 2026 · NCT07094516Olfactory Biopsies
- Duke University Health Center, Durham
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 jun 2026 · NCT07021040A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
- Duke Early Phase Research Unit, Durham
ReclutandoFase 1Se aceptan voluntarios sanos
Edades de 45 a 85 · Todos los sexos · Actualizado el 4 jun 2026 · NCT06657768Late Onset Alzheimer's Disease
- North Carolina State University, Raleigh
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 55 en adelante · Todos los sexos · Actualizado el 18 may 2026 · NCT05010603Connect-Home: Alzheimer's Disease and Related Dementias
- University of North Carolina at Chapel Hill, Chapel Hill
Reclutando
Edades de 19 en adelante · Todos los sexos · Actualizado el 30 mar 2026 · NCT06840587Wake Forest Alzheimer's Disease Clinical Core
- Wake Forest Baptist Health, Winston-Salem
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 55 en adelante · Todos los sexos · Actualizado el 27 mar 2026 · NCT03140865Retinal Imaging in Neurodegenerative Disease
- Duke University Medical Center, Durham
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 feb 2026 · NCT03233646Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Matthews
ReclutandoFase 2
Edades de 50 a 85 · Todos los sexos · Actualizado el 2 feb 2026 · NCT07105709De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.